Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out how safe and effective the combination of Mylotarg
in combination with cytarabine is in treating patients with Acute Myeloid Leukemia and
advanced Myelodysplastic Syndrome over the age of 60 years.